Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Medicare to Negotiate Lower Prices for Weight-Loss Drugs

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.

Rebecca Robbins
Author: Rebecca Robbins

Written by

Rebecca Robbins

in

Drugs (Pharmaceuticals), GLP-1 RAs (Drug), Health and Human Services Department, Health Insurance and Managed Care, Medicare, Novo Nordisk A/S, Obesity, Ozempic (Drug), Prices (Fares, Fees and Rates), United States Politics and Government
←Social Media Users Shut Down GOP Senator Over His Out-Of-Control Disasters Claim
Seth Meyers Wants Biden To Do 1 ‘Wicked’ Thing At Donald Trump’s Inauguration→

More posts

  • Pure Joy: Photographer Laylah Amatullah Barrayn Captures Her First ESSENCE Festival Of Culture

  • Angry crowd confronts Republican Rep. Mike Flood at Nebraska town hall

  • Rhea Seehorn celebrates her ‘Pluribus’ Emmy nomination as she waits to hear about Carol and the atom bomb

  • Emmy Nominations Analysis: ‘The Pitt’ And ‘Hacks’ Dominance Proves It Helps To Be On A Show Voters Actually Watch

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube